Aveline Neo studied her Bachelor (Honors) degree with the National University of Singapore (NUS) in the area of cell and molecular biology. After working a few years with the Research and Development teams in GlaxoSmithKline and MSD, she went on to pursue her PhD in NUS with Professor Markus Wenk. She was an industry-linked scholar with Agilent Technologies under the Singapore Economic Development Board-Industrial Postgraduate Programme. Her project was on human tuberculosis lipidomics, using liquid chromatography mass spectrometry analysis.
In 2017, she joined Babraham Institute as a ppost-doc in the signalling group with Professor Michael Wakelam, working on hepatocellular cancer lipidomics.